Emergency management of patients being treated with oral anticoagulants

oral anticoagulants, emergency treatment.
Submitted: 28 January 2013
Accepted: 10 April 2013
Published: 17 December 2013
Abstract Views: 1014
PDF: 803
HTML: 300
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Vitamin K antagonists (VKA) are among the most widely prescribed drugs in the industrialized world. In fact, for decades, VKA have been the only orally available anticoagulant for the primary and secondary prevention of venous and arterial thrombotic events. Their efficacy has been widely demonstrated in a series of studies carried out in the 1990s. Since the incidences of atrial fibrillation and venous thromboembolism increase exponentially with age, the number of anticoagulated patients is destined to increase. This paper examines anticoagulation therapy management with particular attention to the use of VKA.



PlumX Metrics


Download data is not yet available.


How to Cite

Manzato, F., & Franchini, M. (2013). Emergency management of patients being treated with oral anticoagulants. Italian Journal of Medicine, 7(4), 234–241. https://doi.org/10.4081/itjm.2013.234